Monthly Archives: April 2026

Health Care

Overcoming Obstacles: Parkinson’s Treatment Journey to King’s College Hospital

International Parkinson’s Patient Travels Over 18 Hours to Dubai for Advanced Treatment at King’s College Hospital London, Dubai

When Care Cannot Wait: Parkinson’s Patient Travels Across Continents to King’s College Hospital London, Dubai

Global Demand for Advanced Care Remains Strong: Parkinson’s Patient Travels 18 Hours to King’s College Hospital London, Dubai

Dubai, UAE – Parkinson’s disease does not stop for conflict, uncertainty, or distance. For people with advanced neurological conditions, timely specialist care is always needed. This was clear in the journey of a 57-year-old man who traveled to Dubai for treatment at King’s College Hospital Dubai, overcoming several disruptions along the way.

Continue reading Overcoming Obstacles: Parkinson’s Treatment Journey to King’s College Hospital →
Business & Investments

UAE’s Digital Payments Strengthened by Visa and Emirates NBD

• Partnership strengthens the UAE’s digital payments infrastructure with flexible AED settlement of Visa’s domestic transactions, benefiting UAE entities

Dubai, UAE, 30 April  2026:  Visa, a world leader in digital payments, has appointed Emirates NBD, a leading banking group in the Middle East, North Africa and Türkiye (MENAT) region, as its official National Net Settlement Service (NNSS) Agent in the UAE, allowing Visa’s domestic card transactions to be settled by Emirates NBD locally in UAE Dirhams (AED) in lieu of international settlement. The collaboration enhances the UAE’s domestic settlement capabilities and equips Visa clients with greater flexibility to automate and manage their local settlement obligations.

Continue reading UAE’s Digital Payments Strengthened by Visa and Emirates NBD →
Health Care

Oral Semaglutide Trial: Breakthrough for Type 2 Diabetes in Teens

Dubai, UAE – April 30, 2026: Novo Nordisk today announced positive topline results from PIONEER TEENS, a phase 3a trial evaluating oral semaglutide for type 2 diabetes in children and adolescents aged 10–17 years with type 2 diabetes. Oral semaglutide demonstrated a superior reduction in HbA1c (a measure of blood sugar control) over placebo in the trial and showed a well-tolerated safety profile consistent with previous Novo Nordisk semaglutide trials. Oral semaglutide is available today as Rybelsus® in the EU and US and will be available in the US as Ozempic® pill soon.

Dr. Motaz Azzam – senior pediatric endocrinology fellow – Al Jalila Children’s Hospital

Continue reading Oral Semaglutide Trial: Breakthrough for Type 2 Diabetes in Teens →
Business & Investments

Ghitha Holding Reports 23% Revenue Growth in Q1 2026

  • Revenue increased by 23% YoY to AED 1.62 billion, driven by organic growth and sustained demand across essential food segments
  • Gross profit up 8% YoY, driven by revenue growth and continued optimisation across operations
  • Completed acquisition of “Taaza” under NRTC to advance vertical integration in fresh produce

Abu Dhabi, UAE – 30 April 2026: Ghitha Holding PJSC (“Ghitha” or the “Group”; ADX: Ghitha), a diversified conglomerate spanning agriculture, food production, and distribution, and a subsidiary of 2PointZero, has announced its consolidated financial results for the three-month period ended 31 March 2026.

Falal Ameen, CEO of Ghitha Holding,

Continue reading Ghitha Holding Reports 23% Revenue Growth in Q1 2026 →
Featured

UAE PAVILION AT EXPO 2025 OSAKA AWARDED GOLD

 AT iF DESIGN AWARD 2026

Recognition acknowledges the Pavilion’s interior architecture and visitor experience within the category Trade Fairs and Temporary Exhibitions

Abu Dhabi / Tokyo, April 30, 2026: The United Arab Emirates Pavilion at Expo 2025 Osaka has been awarded Gold at the iF Design Award 2026 in the category Interior Architecture – Trade Fairs / Temporary Exhibitions, placing it among a select group of globally recognised design achievements.

Continue reading UAE PAVILION AT EXPO 2025 OSAKA AWARDED GOLD →